259 related articles for article (PubMed ID: 32325050)
1. Listeria Phages Induce Cas9 Degradation to Protect Lysogenic Genomes.
Osuna BA; Karambelkar S; Mahendra C; Christie KA; Garcia B; Davidson AR; Kleinstiver BP; Kilcher S; Bondy-Denomy J
Cell Host Microbe; 2020 Jul; 28(1):31-40.e9. PubMed ID: 32325050
[TBL] [Abstract][Full Text] [Related]
2. Critical Anti-CRISPR Locus Repression by a Bi-functional Cas9 Inhibitor.
Osuna BA; Karambelkar S; Mahendra C; Sarbach A; Johnson MC; Kilcher S; Bondy-Denomy J
Cell Host Microbe; 2020 Jul; 28(1):23-30.e5. PubMed ID: 32325051
[TBL] [Abstract][Full Text] [Related]
3. Cas9 degradation in human cells using phage anti-CRISPR proteins.
Meacham Z; de Tacca LA; Bondy-Denomy J; Rabuka D; Schelle M
PLoS Biol; 2023 Dec; 21(12):e3002431. PubMed ID: 38064533
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of an anti-CRISPR protein, AcrIIA1.
Ka D; An SY; Suh JY; Bae E
Nucleic Acids Res; 2018 Jan; 46(1):485-492. PubMed ID: 29182776
[TBL] [Abstract][Full Text] [Related]
5. Not Your Typical Anti-CRISPR.
Johnson WE
Cell Host Microbe; 2020 Jul; 28(1):1-2. PubMed ID: 32645350
[TBL] [Abstract][Full Text] [Related]
6. Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer.
Mahendra C; Christie KA; Osuna BA; Pinilla-Redondo R; Kleinstiver BP; Bondy-Denomy J
Nat Microbiol; 2020 Apr; 5(4):620-629. PubMed ID: 32218510
[TBL] [Abstract][Full Text] [Related]
7. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.
Rauch BJ; Silvis MR; Hultquist JF; Waters CS; McGregor MJ; Krogan NJ; Bondy-Denomy J
Cell; 2017 Jan; 168(1-2):150-158.e10. PubMed ID: 28041849
[TBL] [Abstract][Full Text] [Related]
9. Anti-CRISPR AcrIIC3 discriminates between Cas9 orthologs via targeting the variable surface of the HNH nuclease domain.
Kim Y; Lee SJ; Yoon HJ; Kim NK; Lee BJ; Suh JY
FEBS J; 2019 Dec; 286(23):4661-4674. PubMed ID: 31389128
[TBL] [Abstract][Full Text] [Related]
10. Prophage integration into CRISPR loci enables evasion of antiviral immunity in Streptococcus pyogenes.
Varble A; Campisi E; Euler CW; Maguin P; Kozlova A; Fyodorova J; Rostøl JT; Fischetti VA; Marraffini LA
Nat Microbiol; 2021 Dec; 6(12):1516-1525. PubMed ID: 34819640
[TBL] [Abstract][Full Text] [Related]
11. Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins.
Hynes AP; Rousseau GM; Agudelo D; Goulet A; Amigues B; Loehr J; Romero DA; Fremaux C; Horvath P; Doyon Y; Cambillau C; Moineau S
Nat Commun; 2018 Jul; 9(1):2919. PubMed ID: 30046034
[TBL] [Abstract][Full Text] [Related]
12. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting.
Goldberg GW; Jiang W; Bikard D; Marraffini LA
Nature; 2014 Oct; 514(7524):633-7. PubMed ID: 25174707
[TBL] [Abstract][Full Text] [Related]
13. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
[TBL] [Abstract][Full Text] [Related]
14. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1.
Zhu Y; Yin S; Li Z
Biochem Biophys Res Commun; 2023 Apr; 654():34-39. PubMed ID: 36878037
[TBL] [Abstract][Full Text] [Related]
16. The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.
Borges AL; Davidson AR; Bondy-Denomy J
Annu Rev Virol; 2017 Sep; 4(1):37-59. PubMed ID: 28749735
[TBL] [Abstract][Full Text] [Related]
17. A functional type II-A CRISPR-Cas system from Listeria enables efficient genome editing of large non-integrating bacteriophage.
Hupfeld M; Trasanidou D; Ramazzini L; Klumpp J; Loessner MJ; Kilcher S
Nucleic Acids Res; 2018 Jul; 46(13):6920-6933. PubMed ID: 30053228
[TBL] [Abstract][Full Text] [Related]
18. Review of CRISPR-Cas Systems in
Espinoza-Mellado MDR; Vilchis-Rangel RE
Int J Microbiol; 2022; 2022():9829770. PubMed ID: 35502187
[No Abstract] [Full Text] [Related]
19. Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6.
Fuchsbauer O; Swuec P; Zimberger C; Amigues B; Levesque S; Agudelo D; Duringer A; Chaves-Sanjuan A; Spinelli S; Rousseau GM; Velimirovic M; Bolognesi M; Roussel A; Cambillau C; Moineau S; Doyon Y; Goulet A
Mol Cell; 2019 Dec; 76(6):922-937.e7. PubMed ID: 31604602
[TBL] [Abstract][Full Text] [Related]
20. An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9.
Hynes AP; Rousseau GM; Lemay ML; Horvath P; Romero DA; Fremaux C; Moineau S
Nat Microbiol; 2017 Oct; 2(10):1374-1380. PubMed ID: 28785032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
